Guided Tissue Regeneration Protocol for Spinal Cord Injuries: A Proposal for Universal Access to Functional Restoration

Abstract This article presents an innovative protocol for the treatment of complete and incomplete spinal cord injuries, which cause paraplegia and tetraplegia. The method is based on Guided Tissue Regeneration, a process that combines selective enzymatic debridement of glial scarring (Phase A) with guided axonal expansion and synchronous remyelination (Phase B). The protocol utilizes the spinal cord's own anatomical structure as a natural conduit for the restoration of nerve pathways, overcoming biological barriers that prevent natural healing. The technology, developed in December 2025, is presented as public domain knowledge, with the explicit purpose of democratizing access to healthcare. As an ethical guideline, it is established that companies and industries utilizing this protocol for commercial exploitation and production of supplies must allocate 10% of their net profits to the UN for global humanitarian aid and 10% to a Global Access Fund for Regenerative Therapies, ensuring the sustainability and distribution of the therapy in economically vulnerable regions. This work reaffirms the commitment to integrate biotechnological advancement with global social responsibility.